Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00828555
First received: January 22, 2009
Last updated: October 15, 2012
Last verified: September 2012

January 22, 2009
October 15, 2012
November 2008
April 2009   (final data collection date for primary outcome measure)
Implementation and measurement of a health services intervention in community or private Ob/Gyn practices to improve the delivery of standard clinical care to vaccinate women against human papillomavirus, influenza, & pertussis. [ Time Frame: Full-scale program implementation will cover a 12 month period, tentatively planned to begin in April 2009. ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00828555 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

PURPOSE To develop, implement, and evaluate the effectiveness of a program designed to assist community Ob/Gyns in vaccinating adolescent and adult women against vaccine-preventable diseases.

SPECIFIC AIMS

  1. Determine the feasibility of implementing a successful vaccination program for adolescent and adult women in Ob/Gyn offices by direct assessment of medical personnel & office staff on their:

    • Attitudes towards vaccination of women against preventable diseases
    • Perceived barriers to implementing a program to vaccinate women in their offices
    • Ideas on how to overcome barriers to successful program implementation
    • Current vaccination practices and office-specific administrative processes
  2. Design & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis
  3. Determine the effectiveness of the vaccination program based on

    • Pre- and post-program vaccination rates
    • Program satisfaction amongst Ob/Gyn providers and office staff
    • Willingness to continue and possibly extend the program to additional vaccines
  4. Quantify the level of support and resources needed to develop and implement the vaccination program
Not Provided
Observational
Not Provided
Not Provided
Not Provided
Non-Probability Sample

Population Groups:

Adults

Minors

Patients

Pregnant Women

Fetuses

  • Influenza Vaccine
  • Papillomavirus Infection
  • Pertussis
Other: Vaccination Program
Design & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
3988
February 2012
April 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 4-5 community Ob/Gyn practices
Female
12 Years to 26 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00828555
Pro00011038
No
Duke University
Duke University
Centers for Disease Control and Prevention
Principal Investigator: Geeta Swamy, MD Duke University
Duke University
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP